Add-on Acquisition • Consumer Products

Organigram Acquires Motif Labs

On December 6, 2024, Organigram acquired consumer products company Motif Labs for 90M USD

Acquisition Context

This is Organigram’s 3rd transaction in the Consumer Products sector.
This is Organigram’s largest (disclosed) transaction.
This is Organigram’s 3rd transaction in Canada.
This is Organigram’s 1st transaction in Ontario.

Explore All 2386 Add-on Acquisition Consumer Products Deals - Search the Database Free

M&A Deal Summary
Date	December 6, 2024
Target	Motif Labs
Sector	Consumer Products
Buyer(s)	Organigram
Deal Type	Add-on Acquisition
Deal Value	90M USD
Advisor(s)	Jefferies (Financial) Davies Ward Phillips & Vineberg (Legal)

Target Company

Motif Labs

Aylmer, Ontario, Canada

Motif Labs is a brand house shaping Canada's cannabis 2.0 market with a portfolio of iconic brands, including BOXHOT (cannabis vape brand), DEBUNK (liquid diamonds vape brand), Rizzlers, and Floe State. Motif Labs was founded in 2017 and is based in Aylmer, Ontario.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Organigram

Toronto, Ontario, Canada

Category	Company
Founded	2010
Sector	Consumer Products
Employees	914
Revenue	160M CAD (2024)

DESCRIPTION

Organigram is a producer of cannabis and cannabis-derived products in Canada and The Edibles and Infusions Corporation, a licensed manufacturer of cannabis-infused soft chews in Canada. Organigram was founded in 2010 and is based in Toronto, Ontario.

Deal Context for Buyer	#
Overall	4 of 4
Sector: Consumer Products	3 of 3
Type: Add-on Acquisition	2 of 2
State: Ontario	1 of 1
Country: Canada	3 of 3
Year: 2024	2 of 2
Size (of disclosed)	1 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2024-06-25	Sanity Group Berlin, Germany Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2024-06-25

Sanity Group

Berlin, Germany

Sanity Group improves people’s quality of life through the use of cannabinoids and the endocannabinoid system. In addition to pharmaceuticals, the focus is also on well-being and cosmetic products that utilize cannabinoids. The group comprises Vayamed and AVAAY Medical (medicinal cannabis), Endosane Pharmaceuticals (minority investment in finished pharmaceuticals), and VAAY (wellbeing). Sanity Group was formed in 2018 and is based in Berlin, Germany.

Buy

Explore Related M&A Activity

Consumer Products M&A - Add-on Acquisition M&A Deals - Ontario M&A - Canada M&A - 2024 M&A